Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Cancer Research

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11489818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor progression: defining the soil round the tumor seed.

  2001cited by this paper
• Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

  2000cited by this paper
• Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer

  2000cited by this paper
• Matrix metalloproteinases: biologic activity and clinical implications.

  2000cited by this paper
• Gelatinase A-immunoreactive protein in ovarian lesions- prognostic value in epithelial ovarian cancer.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor*

  1999cited by this paper
• Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

  1998cited by this paper
• Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion

  1998cited by this paper
• The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.

  1998cited by this paper
• The biology of ovarian cancer.

  1998cited by this paper
• Plasminogen activator inhibitor‐1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

  1998cited by this paper
• Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy

  1997cited by this paper
• Production of extracellular matrix‐degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

  1997cited by this paper
• The AP-1 site and MMP gene regulation: what is all the fuss about?

  1997cited by this paper
• Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants

  1997cited by this paper
• Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.

  1996cited by this paper
• Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*)

  1996cited by this paper
• Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas

  1996cited by this paper
• Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

  1996cited by this paper
• High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

  1996cited by this paper
• Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.

  1996cited by this paper
• 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological study.

  1996cited by this paper
• Expression of urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in benign, borderline, malignant primary and metastatic ovarian tumors

  1996cited by this paper
• Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

  1995cited by this paper
• Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.

  1995cited by this paper
• Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.

  1995cited by this paper
• Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.

  1995cited by this paper
• Expression and activity of MMPS and their regulators in ovarian cancer

  1994cited by this paper
• Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinoma

  1994cited by this paper
• Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

  1993cited by this paper
• Activity of type IV collagenases in benign and malignant breast disease.

  1993influential reference
• The plasminogen‐activation system in ovarian tumors

  1993cited by this paper
• Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the Ovary

  1992cited by this paper
• Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

  1990cited by this paper
• Detergent-activation of latent collagenase and resolution of its component molecules.

  1982cited by this paper
• © 1999 Cancer Research Campaign Article no. bjoc.1998.0278 Prognostic significance of urokinase (uPA) and its

  year unknowncited by this paper

• Advanced sensing strategies for detecting zinc levels and zinc-related biomarkers in cancer pathogenesis

  2025cites this paper
• Enhancing immunotherapy with tumour-responsive nanomaterials

  2025influential citation
• Non-coding RNA RMRP governs RAB31-dependent MMP secretion, enhancing ovarian cancer invasion.

  2025cites this paper
• A review of matrix Metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy.

  2024cites this paper
• Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma

  2024cites this paper
• Caregiver burden and risk of epithelial ovarian cancer in the Nurses' Health Studies.

  2024cites this paper
• Annexin A2: the feasibility of being a therapeutic target associated with cancer metastasis and drug resistance in cancer microenvironment

  2024cites this paper
• Amentoflavone, a potent natural matrix metalloproteinase 2 inhibitor

  2023cites this paper
• A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis.

  2023cites this paper
• Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition.

  2023cites this paper
• Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment.

  2022cites this paper
• NGAL/MMP-9 as a Biomarker for Epithelial Ovarian Cancer: A Case–Control Diagnostic Accuracy Study

  2022cites this paper
• Bioorthogonal PEGylation Prolongs the Elimination Half-Life of N-TIMP2 While Retaining MMP Inhibition.

  2022cites this paper
• Tumor-specific imaging probes in preclinical applications and clinical trials

  2022cites this paper
• Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma

  2022cites this paper
• Synthesis, Characterization, Molecular Docking and Molecular Dynamics Simulations of Benzamide Derivatives as Potential Anti-Ovarian Cancer Agents

  2022cites this paper
• The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine

  2022cites this paper
• The role of mixed lineage kinase 3 (MLK3) in cancers.

  2022cites this paper
• The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets

  2022cites this paper
• RETRACTED ARTICLE: PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance

  2021cites this paper
• Metalloproteinases in Ovarian Cancer

  2021cites this paper
• In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation.

  2021cites this paper
• Triangulating the pharmacological properties of thymoquinone in regulating reactive oxygen species, inflammation, and cancer: Therapeutic applications and mechanistic pathways.

  2021cites this paper
• Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles

  2020cites this paper
• Thyroid tumor cells-fibroblasts crosstalk: role of extracellular vesicles

  2020cites this paper
• Role of trypsin and protease-activated receptor-2 in ovarian cancer

  2020cites this paper
• Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles.

  2020cites this paper
• Tetrandrine inhibits cell migration and invasion in human nasopharyngeal carcinoma NPC-TW 039 cells through inhibiting MAPK and RhoA signaling pathways.

  2020cites this paper
• Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

  2020cites this paper
• The functions of CAP superfamily proteins in mammalian fertility and disease.

  2020cites this paper
• Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.

  2020cites this paper
• Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications

  2020cites this paper
• Morphometric and Vascular Analyses and MMP-2 Expression in Bladders of Animals with Bovine Enzootic Haematuria

  2020cites this paper
• Polysaccharides from Poria cocos (PCP) inhibits ox-LDL-induced vascular smooth muscle cells proliferation and migration by suppressing TLR4/NF-κB p65 signaling pathway

  2019cites this paper
• Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial

  2019cites this paper
• Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

  2019cites this paper
• Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma

  2019cites this paper
• Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions

  2019cites this paper
• Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform.

  2019cites this paper
• MMP-2 mRNA Expression in Ovarian Cancer Tissues Predicts Patients' Response to Platinum-Taxane Chemotherapy

  2019cites this paper
• Cyclodextrin-based sustained gene release systems: a supramolecular solution towards clinical applications

  2019cites this paper
• HDAC3 positively regulates HE4 expression to promote ovarian carcinoma progression.

  2019cites this paper
• Peptide P7 inhibits the bFGF-stimulated proliferation and invasion of SKOV3 cells

  2019cites this paper
• Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling

  2019cites this paper
• Immunohistochemical Expression of Matrix Metalloproteinase-2 ( MMP-2 ) in Benign Ovarian Cyst at Adam Malik General Hospital in 2017

  2019cites this paper
• Structure Identification of ViceninII Extracted from Dendrobium officinale and the Reversal of TGF-β1-Induced Epithelial–Mesenchymal Transition in Lung Adenocarcinoma Cells through TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways

  2019cites this paper
• Three New Scorpion Chloride Channel Toxins as Potential Anti-Cancer Drugs: Computational Prediction of The Interactions With Hmmp-2 by Docking and Steered Molecular Dynamics Simulations

  2019cites this paper
• The past, present and future perspectives of matrix metalloproteinase inhibitors.

  2019cites this paper
• HPV16-E6 Oncoprotein Activates TGF-β and Wnt/β-Catenin Pathways in the Epithelium-Mesenchymal Transition of Cataracts in a Transgenic Mouse Model

  2018cites this paper
• Gelidiella acerosa inhibits lung cancer proliferation

  2018cites this paper
• Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control

  2018cites this paper
• Prevalence of matrix metalloproteinase (MMP-9) in urinary bladder cancer

  2018cites this paper
• Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia

  2018cites this paper
• Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe

  2018cites this paper
• Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers

  2018cites this paper
• Activin A target genes are differentially expressed between normal and neoplastic adult human testes: clues to gonocyte fate choice

  2018cites this paper
• Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells

  2018cites this paper
• Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway.

  2018cites this paper
• High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-κB-Dependent Manner

  2018cites this paper
• High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma

  2018cites this paper
• Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.

  2018cites this paper
• Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.

  2018cites this paper
• Behandlung der multiplen aktinischen Keratose und Feldkanzerisierung mit topischem Piroxicam 0,8% und Sonnenschutz (LSF 50+) bei Organtransplantat-Empfängern: Eine Serie von 10 Fällen

  2018cites this paper
• Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility.

  2018cites this paper
• miR-144-3p Targets FosB Proto-oncogene, AP-1 Transcription Factor Subunit (FOSB) to Suppress Proliferation, Migration, and Invasion of PANC-1 Pancreatic Cancer Cells

  2018cites this paper
• MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.

  2018cites this paper
• Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial

  2017cites this paper
• Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery.

  2017cites this paper
• Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer

  2017cites this paper
• Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.

  2017cites this paper
• Molecular imaging of the tumor microenvironment☆

  2017cites this paper
• Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O2 and Plasma Supply

  2017cites this paper
• CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway

  2017cites this paper
• Smart design and in vitro testing of nanoparticles for microenvironmentally-triggered extracellular drug release

  2017cites this paper
• Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

  2017cites this paper
• Tumor Microenvironment Responsive ACPP‐Conjugated Micelles for Targeted Treatment of Brain Glioma

  2017cites this paper
• EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion

  2017cites this paper
• The expression of the BRM and MMP2 genes in thoracic aortic aneurysm and aortic dissection.

  2017cites this paper
• 3,4',7-O-trimethylquercetin Inhibits Invasion and Migration of Ovarian Cancer Cells.

  2017cites this paper
• Soft drug-resistant ovarian cancer cells invade via two distinct mechanisms utilizing myosin IIB

  2017cites this paper
• MKL1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion.

  2017cites this paper
• Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases

  2017cites this paper
• Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial–mesenchymal transition

  2017cites this paper
• Anti-inflammatory Property of β-D-Mannuronic Acid (M2000) on Expression and Activity of Matrix Metalloproteinase-2 and -9 through CD147 Molecule in Phorbol Myristate Acetate-differentiated THP-1 Cells.

  2017cites this paper
• The Role of MMP9 and WNT Signaling in Peritoneal Angiogenesis

  2017cites this paper
• Enzymatic activation of cell-penetrating peptides in self-assembled nanostructures triggers fibre-to-micelle morphological transition.

  2017cites this paper
• IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte–Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System

  2017cites this paper
• PI 16 is a shear stress and inflammation-regulated inhibitor of MMP 2

  2016cites this paper
• Erratum: PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion

  2016cites this paper
• Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach

  2016cites this paper
• The tumor microenvironment promotes cancer progression and cell migration

  2016cites this paper
• Nonlethal Levels of Zeaxanthin Inhibit Cell Migration, Invasion, and Secretion of MMP-2 via NF-κB Pathway in Cultured Human Uveal Melanoma Cells

  2016cites this paper
• Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.

  2016cites this paper
• Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

  2016cites this paper
• MINOCYCLINE IS MORE POTENT THAN TETRACYCLINE AND DOXYCYCLINE IN INHIBITING MMP-9 IN VITRO

  2016cites this paper
• In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity

  2016cites this paper
• 17β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway

  2016cites this paper
• Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines.

  2016cites this paper
• The role of inflammation and SPARC (secreted protein acidic and rich in cysteine) in colorectal tumourigenesis

  2016cites this paper
• Regulation of MMP2/9 transport to the invadopodia during breast cancer cell invasion

  2016cites this paper